Idexx Laboratories (IDXX) Invested Capital (2009 - 2026)

Idexx Laboratories' Invested Capital history runs 18 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 28.86% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (up 28.86% YoY), while the FY2025 annual figure was $2.1 billion, down 7.13% from the prior year.
• Invested Capital was $2.1 billion for Q1 2026 at Idexx Laboratories, up from $2.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.2 billion in Q4 2024 to a low of $639.8 million in Q1 2022.
• Historically, Invested Capital has averaged $1.6 billion across 5 years, with a median of $1.7 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Invested Capital fell 22.77% in 2022, then soared 70.54% in 2023.
• A 5-year view of Invested Capital shows it stood at $1.4 billion in 2022, then surged by 58.34% to $2.2 billion in 2023, then advanced by 1.39% to $2.2 billion in 2024, then dropped by 7.13% to $2.1 billion in 2025, then climbed by 1.49% to $2.1 billion in 2026.
• The last three Invested Capital figures came in at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.